MedPAC > Our Work > Drugs, Devices, and Tests > Effects of pharmaceutical manufacturer rebates on Part D’s risk adjustment Effects of pharmaceutical manufacturer rebates on Part D’s risk adjustment Nov 09, 2020 / Presentations Download Full Presentation